25.82 -0.59 (-2.24%)
ACOR
| Trade ACOR now with |
|
Stock Details
Last Trade:25.82 Change:-0.59 (-2.24%) Prev Close:26.41 Open: 26.38 Days Range:25.44 – 26.52 52 Week Range: 18.36 - 33.48 Volume:415910 P/E: 48.72EPS:0.53
View AllRecent Alerts 02/09/12
Recent Alert on 01/30/12 at 8:20am
Lazard Capital Downgrades Acorda Therapeutics (ACOR) to Neutral
Lazard Capital Downgrades Acorda Therapeutics (ACOR) to Neutral
Lazard Capital downgraded Acorda Therapeutics (NASDAQ: ACOR) from Buy to Neutral. For an analyst ratings summary and ratings history on Acorda Therapeutics click here. For more ratings news on Acorda Therapeutics click here. Shares of Acorda... Read More
Recent Alert on 01/23/12 at 2:20pm
JPMorgan Downgraded Several Biotech Stocks (ACOR, ALTH, AMAG, AMGN & VPHM)
JPMorgan Downgraded Several Biotech Stocks (ACOR, ALTH, AMAG, AMGN & VPHM)
Recent Alert on 12/28/11 at 7:42am
Short Interest Ticks Up in Large-Cap Biotech, Specifically Amgen (AMGN)
Short Interest Ticks Up in Large-Cap Biotech, Specifically Amgen (AMGN)
View AllRecent Press Releases
Press Release on 02/09/12 at 9:00am
A Forward Look, the Year Ahead - Featured Research on Acorda Therapeutics Inc and Abbott Laboratories
A Forward Look, the Year Ahead - Featured Research on Acorda Therapeutics Inc and Abbott Laboratories
Press Release on 02/09/12 at 6:01am
Acorda Therapeutics to Present at Leerink Swann 2012 Global Healthcare Conference
Acorda Therapeutics to Present at Leerink Swann 2012 Global Healthcare Conference
Press Release on 02/09/12 at 6:00am
Acorda Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2011 Financial Results on February 16, 2012
Acorda Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2011 Financial Results on February 16, 2012
Press Release on 02/07/12 at 6:00am
Acorda Therapeutics to Present at 14th Annual BIO CEO & Investor Conference
Acorda Therapeutics to Present at 14th Annual BIO CEO & Investor Conference
Press Release on 02/06/12 at 4:15pm
Acorda Therapeutics Announces Launch of Authorized Generic Version of ZANAFLEX CAPSULES®
Acorda Therapeutics Announces Launch of Authorized Generic Version of ZANAFLEX CAPSULES®
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 02/07/12 at 3:46pm
3 Biotech Stocks Reporting Earnings Next Week With A Decreasing Number Of Shorts
3 Biotech Stocks Reporting Earnings Next Week With A Decreasing Number Of Shorts
Blog Posts on 01/19/12 at 5:07pm
Elan: Between Speculation And Reality, Where Is The Firm Headed Now?
Elan: Between Speculation And Reality, Where Is The Firm Headed Now?